Improved vascular function upon pioglitazone treatment in type 2 diabetes is not associated with changes in mononuclear NF-κB binding activity

G. Rudofsky, P. Reismann, I. A. Grafe, I. Konrade, Z. Djuric, J. Tafel, S. Buchbinder, M. Zorn, P. M. Humpert, A. Hamann, M. Morcos, P. P. Nawroth, A. Bierhaus

Research output: Contribution to journalArticlepeer-review

12 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Improved vascular function upon pioglitazone treatment in type 2 diabetes is not associated with changes in mononuclear NF-κB binding activity'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds